References
- Barnett PG. Review of methods to determine VA health care costs. Med Care 1999; 37: AS9–17.
- Fetter RB. Case-mix definitions by diagnosis-related groups. Med Care 1980; 18: 1–53.
- Solon JA, Feeney JJ, Jones SH, Rigg RD, Sheps CG. Delineating episodes of medical care. Am J Public Health 1967; 57: 401–8.
- Wingert TD, Kralewski JE, Lindquist TJ, Knutson DJ. Constructing episodes of care from encounter and claims data: some methodological issues. Inquiry 1995; 32: 430–3.
- Carlsson P. Hjertberg H, Jonsson B, Varenhorst E. The cost of prostatic cancer in a defined population. Scand J Urol Nephrol 1989; 23: 93–6.
- Holmberg H, Carlsson P. Kalman D, Varenhorst E. Impact on health service cost of medical technologies used in management of prostatic cancer. Scand J Urol Nephrol 1998; 32: 195–9.
- Ruchlin HS, Pellissier JM. An economic overview of prostate carcionoma. Cancer 2001; 92: 2796–810.
- Socialstyrelsen Cancer incidence in Sweden 1999. Stockholm: Socialstyrelsen, 2001.
- Drummond MF Principles of economic appraisal in health care. Oxford, UK: Oxford University Press, 1980.
- Chamberlain J, Melia J, Moss S, Brown J. The diagnosis, management, treatment and costs of prostate cancer in England and Wales. Health Technol Assess 1997; li—vi: 1–53.
- Lithman T, Noreen D, Merlo J. Läkemedel i Skine 2000. Lund, Sweden: Regionkontoret Region Sline. Report 2000: 2 2001.
- The Swedish Council on Technology Assessment in Health Care. Treatment of urinary incontinence, No. 143 Stockholm: SBU, 2000 (in Swedish).